ProfileGDS4718 / 210471_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 37% 72% 37% 37% 31% 34% 37% 43% 39% 35% 38% 37% 35% 32% 34% 42% 34% 41% 32% 35% 38% 38% 42% 37% 38% 42% 29% 38% 39% 37% 35% 35% 38% 33% 33% 36% 36% 36% 68% 38% 40% 37% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8167936
GSM549102patient 115, normal, homogenized [OPG study]4.8899837
GSM549104patient 119, normal, homogenized [OPG study]7.0760572
GSM549108patient 138, normal, homogenized [OPG study]4.8977337
GSM549119patient 077, normal, homogenized [OPG study]4.8476937
GSM549133patient 032, cancer, homogenized [OPG study]4.54831
GSM549139patient 042, cancer, homogenized [OPG study]4.6786934
GSM549099patient 107, normal, homogenized [OPG study]4.873637
GSM549109patient 139, normal, homogenized [OPG study]5.1608343
GSM549110patient 046, normal, homogenized [OPG study]4.9642439
GSM549114patient 063, normal, homogenized [OPG study]4.7307935
GSM549122patient 082, normal, homogenized [OPG study]4.8899638
GSM549134patient 033, cancer, homogenized [OPG study]4.8252137
GSM549136patient 036, cancer, homogenized [OPG study]4.7006635
GSM549140patient 044, cancer, homogenized [OPG study]4.5632732
GSM549111patient 047, normal, homogenized [OPG study]4.6760134
GSM549113patient 057, normal, homogenized [OPG study]5.0507642
GSM549132patient 031, cancer, homogenized [OPG study]4.713434
GSM549137patient 038, cancer, homogenized [OPG study]5.0154341
GSM549142patient 047, cancer, homogenized [OPG study]4.7369932
GSM549100patient 110, normal, homogenized [OPG study]4.7690335
GSM549107patient 135, normal, homogenized [OPG study]4.8524438
GSM549115patient 068, normal, homogenized [OPG study]4.8163438
GSM549116patient 072, normal, homogenized [OPG study]5.0411342
GSM549120patient 078, normal, homogenized [OPG study]4.852737
GSM549131patient 030, cancer, homogenized [OPG study]4.8314838
GSM549118patient 074, normal, homogenized [OPG study]5.0707842
GSM549129patient 027, cancer, homogenized [OPG study]4.4983729
GSM549123patient 088, normal, homogenized [OPG study]4.8682438
GSM549124patient 006, cancer, homogenized [OPG study]4.9648539
GSM549126patient 015, cancer, homogenized [OPG study]4.8462837
GSM549128patient 025, cancer, homogenized [OPG study]4.7617235
GSM549103patient 117, normal, homogenized [OPG study]4.842735
GSM549117patient 073, normal, homogenized [OPG study]4.8412538
GSM549138patient 041, cancer, homogenized [OPG study]4.6401433
GSM549141patient 045, cancer, homogenized [OPG study]4.6052133
GSM549130patient 028, cancer, homogenized [OPG study]4.8133936
GSM549101patient 111, normal, homogenized [OPG study]4.8493236
GSM549105patient 128, normal, homogenized [OPG study]4.8351636
GSM549106patient 134, normal, homogenized [OPG study]6.7764168
GSM549112patient 048, normal, homogenized [OPG study]4.9040838
GSM549125patient 011, cancer, homogenized [OPG study]5.0090840
GSM549127patient 024, cancer, homogenized [OPG study]4.8396837
GSM549135patient 035, cancer, homogenized [OPG study]4.5021330